In diagnostic practice, while TFE3 immunohistochemistry demonstrates high sensitivity, its specificity is limited; therefore, detection of ASPSCR1-TFE3 fusion transcripts is regarded as the definitive diagnostic criterion for ASPS (9, 12). Here, TFE3 is linked to alveolar soft part sarcoma.